Aemetis, Inc. (NASDAQ:AMTX) Short Interest Up 5.8% in December

Aemetis, Inc. (NASDAQ:AMTX) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 5,670,000 shares, a growth of 5.8% from the November 30th total of 5,360,000 shares. Based on an average daily volume of 729,000 shares, the days-to-cover ratio is currently 7.8 days.

Wall Street Analyst Weigh In

Several analysts have weighed in on AMTX shares. StockNews.com upgraded shares of Aemetis to a “sell” rating in a research note on Wednesday, December 25th. HC Wainwright reiterated a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research report on Monday, December 23rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Aemetis has a consensus rating of “Moderate Buy” and an average price target of $12.95.

Aemetis Stock Up 4.8 %

AMTX stock opened at $2.82 on Friday. The company’s 50-day moving average price is $3.27 and its two-hundred day moving average price is $2.98. The firm has a market cap of $140.25 million, a P/E ratio of -1.25 and a beta of 1.35. Aemetis has a 12 month low of $2.10 and a 12 month high of $7.03.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same period last year, the business earned ($0.59) earnings per share. Equities analysts predict that Aemetis will post -2.02 EPS for the current year.

Hedge Funds Weigh In On Aemetis

Institutional investors have recently modified their holdings of the business. FMR LLC grew its position in Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after acquiring an additional 9,137 shares during the last quarter. Hutchinson Capital Management CA bought a new stake in shares of Aemetis during the 2nd quarter valued at approximately $70,000. Barclays PLC increased its position in Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after purchasing an additional 34,816 shares in the last quarter. Rhumbline Advisers lifted its stake in Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after purchasing an additional 50,528 shares during the last quarter. Finally, Wellington Management Group LLP acquired a new stake in Aemetis in the third quarter valued at approximately $177,000. Institutional investors and hedge funds own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.